Advances in Neovascular Macular Degeneration From ASRS 2025

Advances in neovascular macular degeneration, presented at ASRS 2025, include efficacy of aflibercept 8 mg as well as emerging gene therapies, as reported by Dr Sunir Garg.
Medscape